This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment

Inclusion Criteria:

• Patients aged more than or equal to (≥) 12 years at the time of consent.

• Confirmed diagnosis of AD, of any severity, according to the Investigator'sassessment as aligned with International Classification of Diseases 10th revision (ICD-10) code of L20.

• Prescribed and scheduled to initiate any systemic treatment for AD (including butnot limited to biologics, oral Janus kinase (JAK) inhibitors, cyclosporine,azathioprine, methotrexate, mycophenolate mofetil)

• Signed informed consent for registry participation by the patient or parent/legalrepresentative and assent by the patient appropriate to the patient's age, includingwillingness to participate in long-term follow-up.

Exclusion Criteria:

• Concurrent participation in an interventional clinical trial that administers aninvestigational drug that modifies patient care.

• Insufficient understanding of the study by the patient and/or parent/guardian.

The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.